chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pharyngeal swelling, Sinusitis, Upper-airway cough syndrome
Clinical narrative: A real bad sore throat; Felt like a sinus infection; Throat swollen up; Drainage in the back of throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (A real bad sore throat), SINUSITIS (Felt like a sinus infection), PHARYNGEAL SWELLING (Throat swollen up) and UPPER-AIRWAY COUGH SYNDROME (Drainage in the back of throat) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided.     On 22-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (A real bad sore throat), SINUSITIS (Felt like a sinus infection), PHARYNGEAL SWELLING (Throat swollen up) and UPPER-AIRWAY COUGH SYNDROME (Drainage in the back of throat). At the time of the report, OROPHARYNGEAL PAIN (A real bad sore throat), SINUSITIS (Felt like a sinus infection), PHARYNGEAL SWELLING (Throat swollen up) and UPPER-AIRWAY COUGH SYNDROME (Drainage in the back of throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient took self treatment with salt water gargle.
Age: 40.0
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling hot, Influenza like illness, Myalgia
Clinical narrative: Flu like symptoms; I felt hot but wasn't running a fever; Felt like crap; Pain in arm; Felt like my whole body got hit by a truck; Wanted to curl up and go back to sleep for a while; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (I felt hot but wasn't running a fever), ASTHENIA (Felt like crap), VACCINATION SITE PAIN (Pain in arm) and MYALGIA (Felt like my whole body got hit by a truck) in a 40-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESOMEPRAZOLE for Acid reflux (esophageal), CELECOXIB for Neck pain, VALACICLOVIR HYDROCHLORIDE (VALTREX) for Shingles, VALPROATE SEMISODIUM (DEPAKOTE ER), PALIPERIDONE (INVEGA [PALIPERIDONE]), LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (I felt hot but wasn't running a fever), ASTHENIA (Felt like crap), VACCINATION SITE PAIN (Pain in arm), MYALGIA (Felt like my whole body got hit by a truck) and FATIGUE (Wanted to curl up and go back to sleep for a while). The patient was treated with NAPROXEN SODIUM (ALEVE) for Vaccination site pain and Myalgia, at an unspecified dose and frequency. On 29-Mar-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (I felt hot but wasn't running a fever), ASTHENIA (Felt like crap), VACCINATION SITE PAIN (Pain in arm), MYALGIA (Felt like my whole body got hit by a truck) and FATIGUE (Wanted to curl up and go back to sleep for a while) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 40.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Flu like symptoms; I felt hot but wasn't running a fever; Felt like crap; Pain in arm; Felt like my whole body got hit by a truck; Wanted to curl up and go back to sleep for a while; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (I felt hot but wasn't running a fever), ASTHENIA (Felt like crap), VACCINATION SITE PAIN (Pain in arm) and MYALGIA (Felt like my whole body got hit by a truck) in a 40-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESOMEPRAZOLE for Acid reflux (esophageal), CELECOXIB for Neck pain, VALACICLOVIR HYDROCHLORIDE (VALTREX) for Shingles, VALPROATE SEMISODIUM (DEPAKOTE ER), PALIPERIDONE (INVEGA [PALIPERIDONE]), LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (I felt hot but wasn't running a fever), ASTHENIA (Felt like crap), VACCINATION SITE PAIN (Pain in arm), MYALGIA (Felt like my whole body got hit by a truck) and FATIGUE (Wanted to curl up and go back to sleep for a while). The patient was treated with NAPROXEN SODIUM (ALEVE) for Vaccination site pain and Myalgia, at an unspecified dose and frequency. On 29-Mar-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (I felt hot but wasn't running a fever), ASTHENIA (Felt like crap), VACCINATION SITE PAIN (Pain in arm), MYALGIA (Felt like my whole body got hit by a truck) and FATIGUE (Wanted to curl up and go back to sleep for a while) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Gastrointestinal pain, Pain in extremity, Pyrexia, Renal pain
Clinical narrative: Sharp pain in the kidneys; Sharp pain in the gut; Fever; Chills; Arm Pain and legs; This spontaneous case was reported by a consumer and describes the occurrence of RENAL PAIN (Sharp pain in the kidneys), GASTROINTESTINAL PAIN (Sharp pain in the gut), PAIN IN EXTREMITY (Arm Pain and legs), PYREXIA (Fever) and CHILLS (Chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025597407089) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain and legs). On 22-Apr-2021, the patient experienced RENAL PAIN (Sharp pain in the kidneys), GASTROINTESTINAL PAIN (Sharp pain in the gut), PYREXIA (Fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, RENAL PAIN (Sharp pain in the kidneys), GASTROINTESTINAL PAIN (Sharp pain in the gut), PAIN IN EXTREMITY (Arm Pain and legs), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that they received their first dose of the Moderna Covid-19 vaccine and had arm pain. On 22-Apr-2021, the patient had fever and chills and felt sharp pain in the kidneys, gut and legs.  The patient second dose was scheduled for 19-May-2021.  No Concomitant product use was reported.  Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded. However, no information is available regarding medical history/medications that could be confounders/co-suspects for some of the events.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Non significant Follow-up received email address added.; Sender's Comments: Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded. However, no information is available regarding medical history/medications that could be confounders/co-suspects for some of the events.
Sex: F
Vaccine: COVID19
Symptoms: Crying, Depression, Mood altered
Clinical narrative: depression; crying a lot; moods and thoughts are not clear; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSION (depression), CRYING (crying a lot) and MOOD ALTERED (moods and thoughts are not clear) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEPRESSION (depression), CRYING (crying a lot) and MOOD ALTERED (moods and thoughts are not clear). At the time of the report, DEPRESSION (depression), CRYING (crying a lot) and MOOD ALTERED (moods and thoughts are not clear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dysuria, Feeling hot, Myalgia, Vaccination site pain
Clinical narrative: Feeling warm; Strong flow of urine; Body aches; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Feeling warm), DYSURIA (Strong flow of urine), MYALGIA (Body aches) and VACCINATION SITE PAIN (Pain at the injection site) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced FEELING HOT (Feeling warm), DYSURIA (Strong flow of urine), MYALGIA (Body aches) and VACCINATION SITE PAIN (Pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Apr-2021, VACCINATION SITE PAIN (Pain at the injection site) had resolved. At the time of the report, FEELING HOT (Feeling warm), DYSURIA (Strong flow of urine) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Breathing harder after 2nd dose; Can't catch breath after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Breathing harder after 2nd dose) and DYSPNOEA (Can't catch breath after 2nd dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Breathing harder after 2nd dose) and DYSPNOEA (Can't catch breath after 2nd dose). At the time of the report, DYSPNOEA (Breathing harder after 2nd dose) and DYSPNOEA (Can't catch breath after 2nd dose) outcome was unknown. Not Provided          Concomitant medications include Heart pills and Fluid pills. No treatment information provided.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Hypoaesthesia, Lethargy, Pharyngeal swelling
Clinical narrative: dizziness; lethargic; numbness in the arms and legs; difficulty focusing; shortness of breath; swelling in the throat area; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), LETHARGY (lethargic), HYPOAESTHESIA (numbness in the arms and legs), VISION BLURRED (difficulty focusing) and DYSPNOEA (shortness of breath) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced DIZZINESS (dizziness), LETHARGY (lethargic), HYPOAESTHESIA (numbness in the arms and legs), VISION BLURRED (difficulty focusing), DYSPNOEA (shortness of breath) and PHARYNGEAL SWELLING (swelling in the throat area). At the time of the report, DIZZINESS (dizziness), LETHARGY (lethargic), HYPOAESTHESIA (numbness in the arms and legs), VISION BLURRED (difficulty focusing), DYSPNOEA (shortness of breath) and PHARYNGEAL SWELLING (swelling in the throat area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow-up received on 23-04-2021: SD contains new info abt lot number, SD and Email document attached
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: dizziness; lethargic; numbness in the arms and legs; difficulty focusing; shortness of breath; swelling in the throat area; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), LETHARGY (lethargic), HYPOAESTHESIA (numbness in the arms and legs), VISION BLURRED (difficulty focusing) and DYSPNOEA (shortness of breath) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced DIZZINESS (dizziness), LETHARGY (lethargic), HYPOAESTHESIA (numbness in the arms and legs), VISION BLURRED (difficulty focusing), DYSPNOEA (shortness of breath) and PHARYNGEAL SWELLING (swelling in the throat area). At the time of the report, DIZZINESS (dizziness), LETHARGY (lethargic), HYPOAESTHESIA (numbness in the arms and legs), VISION BLURRED (difficulty focusing), DYSPNOEA (shortness of breath) and PHARYNGEAL SWELLING (swelling in the throat area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow-up received on 23-04-2021: SD contains new info abt lot number, SD and Email document attached
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: urticaria kind rash; urticaria kind rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (urticaria kind rash) and RASH (urticaria kind rash) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (urticaria kind rash) and RASH (urticaria kind rash). At the time of the report, URTICARIA (urticaria kind rash) and RASH (urticaria kind rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Wrong technique in product usage process
Clinical narrative: pharmacist punctured a vial and the vial was put back in the refrigerator and the next day, 24 hrs later, 5 doses were administered to 5 patients.; pharmacist punctured a vial and the vial was put back in the refrigerator and the next day, 24 hrs later, 5 doses were administered to 5 patients.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (pharmacist punctured a vial and the vial was put back in the refrigerator and the next day, 24 hrs later, 5 doses were administered to 5 patients.) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (pharmacist punctured a vial and the vial was put back in the refrigerator and the next day, 24 hrs later, 5 doses were administered to 5 patients.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (pharmacist punctured a vial and the vial was put back in the refrigerator and the next day, 24 hrs later, 5 doses were administered to 5 patients.) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (pharmacist punctured a vial and the vial was put back in the refrigerator and the next day, 24 hrs later, 5 doses were administered to 5 patients.). On 22-Apr-2021, EXPIRED PRODUCT ADMINISTERED (pharmacist punctured a vial and the vial was put back in the refrigerator and the next day, 24 hrs later, 5 doses were administered to 5 patients.) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (pharmacist punctured a vial and the vial was put back in the refrigerator and the next day, 24 hrs later, 5 doses were administered to 5 patients.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up  received on 28-May-2021 and does not contain any new information
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia
Clinical narrative: Felt tired; fever of 104 degrees; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 104 degrees) and FATIGUE (Felt tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PYREXIA (fever of 104 degrees). On 09-Mar-2021, the patient experienced FATIGUE (Felt tired). The patient was treated with IBUPROFEN at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at a dose of 1 dosage form and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of 1 dosage form. On 09-Mar-2021, PYREXIA (fever of 104 degrees) and FATIGUE (Felt tired) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 104 (High) 104 degree Fahrenheit.         Treatment included cold compressions. No concomitant medication information was provided.   This case was linked to MOD-2021-035199 (Patient Link).
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16yr old patient received vaccine first dose; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16yr old patient received vaccine first dose) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16yr old patient received vaccine first dose). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16yr old patient received vaccine first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swelling of the lymph nodes underneath the left armpit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling of the lymph nodes underneath the left armpit) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced LYMPHADENOPATHY (swelling of the lymph nodes underneath the left armpit). At the time of the report, LYMPHADENOPATHY (swelling of the lymph nodes underneath the left armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Patient reported that medicines had stopped working.   This case was linked to US-MODERNATX, INC.-MOD-2021-089048, US-MODERNATX, INC.-MOD-2021-089333, MOD21-081044, US-MODERNATX, INC.-MOD-2021-089601 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow up was received on 01 Jun 2021  included non significant information, medication information was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089048:cross linked case US-MODERNATX, INC.-MOD-2021-089333:cross linked case MOD21-081044:cross linked case US-MODERNATX, INC.-MOD-2021-089601:patient 2
Age: 40.0
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster, Pain in extremity
Clinical narrative: Shingles flare up; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles flare up) and PAIN IN EXTREMITY (arm soreness) in a 40-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder, Acid reflux (oesophageal), Neck pain and Shingles. Concomitant products included ESOMEPRAZOLE for Acid reflux (oesophageal), CELECOXIB for Neck pain, VALACICLOVIR HYDROCHLORIDE (VALTREX) for Shingles, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder, VALPROATE SEMISODIUM (DEPAKOTE ER), PALIPERIDONE PALMITATE (INVEGA SUSTENNA) and VITAMIN D NOS for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced HERPES ZOSTER (Shingles flare up) and PAIN IN EXTREMITY (arm soreness). At the time of the report, HERPES ZOSTER (Shingles flare up) and PAIN IN EXTREMITY (arm soreness) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included Aleve for arm soreness.   This case was linked to MOD-2021-089350 (Patient Link).
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: left arm soreness; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm soreness) and PYREXIA (slight fever) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced PAIN IN EXTREMITY (left arm soreness) and PYREXIA (slight fever). At the time of the report, PAIN IN EXTREMITY (left arm soreness) and PYREXIA (slight fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications also included blood pressure medications, Heart medications and Cholesterol medications. No treatment  had received by patient for the symptoms developed
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Ring-like swelling at injection site; Fatigue; light headache; chills; Soreness at injection site; Itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE PRURITUS (Itching at injection site), FATIGUE (Fatigue), HEADACHE (light headache) and CHILLS (chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was provided.     On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE PRURITUS (Itching at injection site). On 21-Apr-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (light headache) and CHILLS (chills). On 22-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Ring-like swelling at injection site). On 22-Apr-2021, VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE PRURITUS (Itching at injection site), FATIGUE (Fatigue), HEADACHE (light headache) and CHILLS (chills) had resolved. At the time of the report, VACCINATION SITE SWELLING (Ring-like swelling at injection site) had resolved. Not Provided          No concomitant medication provided by the reporter no treatment information reported by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up received on 28-may-2021,contain non significant information
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Ring-like swelling at injection site; Fatigue; light headache; chills; Soreness at injection site; Itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE PRURITUS (Itching at injection site), FATIGUE (Fatigue), HEADACHE (light headache) and CHILLS (chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was provided.     On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE PRURITUS (Itching at injection site). On 21-Apr-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (light headache) and CHILLS (chills). On 22-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Ring-like swelling at injection site). On 22-Apr-2021, VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE PRURITUS (Itching at injection site), FATIGUE (Fatigue), HEADACHE (light headache) and CHILLS (chills) had resolved. At the time of the report, VACCINATION SITE SWELLING (Ring-like swelling at injection site) had resolved. Not Provided          No concomitant medication provided by the reporter no treatment information reported by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up received on 28-may-2021,contain non significant information
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling, Pruritus
Clinical narrative: arm swelled up down to elbow crease; arm hot to touch; arm itching; arm very red; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled up down to elbow crease), FEELING HOT (arm hot to touch), PRURITUS (arm itching) and ERYTHEMA (arm very red) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), EZETIMIBE (ZETIA), SERTRALINE and PANTOPRAZOLE for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PERIPHERAL SWELLING (arm swelled up down to elbow crease), FEELING HOT (arm hot to touch), PRURITUS (arm itching) and ERYTHEMA (arm very red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (arm swelled up down to elbow crease), FEELING HOT (arm hot to touch), PRURITUS (arm itching) and ERYTHEMA (arm very red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Limb discomfort, Vaccination site erythema, Vaccination site pain
Clinical narrative: Could not move her arm for three days; Arm was hot; Covid arm; Her arm was extremely itchy for a week; Hives on it for a week; Arm was swollen; Arm was red; Pain in arm; Chills; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), LIMB DISCOMFORT (Could not move her arm for three days), VACCINATION SITE WARMTH (Arm was hot), VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE PRURITUS (Her arm was extremely itchy for a week) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 821a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced DIZZINESS (Dizzy) and CHILLS (Chills). On 02-Apr-2021, the patient experienced LIMB DISCOMFORT (Could not move her arm for three days), VACCINATION SITE WARMTH (Arm was hot), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Her arm was extremely itchy for a week), VACCINATION SITE URTICARIA (Hives on it for a week), VACCINATION SITE SWELLING (Arm was swollen), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE PAIN (Pain in arm). At the time of the report, DIZZINESS (Dizzy), LIMB DISCOMFORT (Could not move her arm for three days), VACCINATION SITE WARMTH (Arm was hot), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE SWELLING (Arm was swollen), VACCINATION SITE ERYTHEMA (Arm was red), VACCINATION SITE PAIN (Pain in arm) and CHILLS (Chills) outcome was unknown and VACCINATION SITE PRURITUS (Her arm was extremely itchy for a week) and VACCINATION SITE URTICARIA (Hives on it for a week) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient concomitant drug also included an unknown statin. No treatment medication details was reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling, Vaccination site urticaria, Vaccination site warmth
Clinical narrative: Could not move her arm for three days; Arm was hot; Covid arm; Her arm was extremely itchy for a week; Hives on it for a week; Arm was swollen; Arm was red; Pain in arm; Chills; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), LIMB DISCOMFORT (Could not move her arm for three days), VACCINATION SITE WARMTH (Arm was hot), VACCINATION SITE REACTION (Covid arm) and VACCINATION SITE PRURITUS (Her arm was extremely itchy for a week) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 821a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced DIZZINESS (Dizzy) and CHILLS (Chills). On 02-Apr-2021, the patient experienced LIMB DISCOMFORT (Could not move her arm for three days), VACCINATION SITE WARMTH (Arm was hot), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Her arm was extremely itchy for a week), VACCINATION SITE URTICARIA (Hives on it for a week), VACCINATION SITE SWELLING (Arm was swollen), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE PAIN (Pain in arm). At the time of the report, DIZZINESS (Dizzy), LIMB DISCOMFORT (Could not move her arm for three days), VACCINATION SITE WARMTH (Arm was hot), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE SWELLING (Arm was swollen), VACCINATION SITE ERYTHEMA (Arm was red), VACCINATION SITE PAIN (Pain in arm) and CHILLS (Chills) outcome was unknown and VACCINATION SITE PRURITUS (Her arm was extremely itchy for a week) and VACCINATION SITE URTICARIA (Hives on it for a week) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient concomitant drug also included an unknown statin. No treatment medication details was reported.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Haemoptysis
Clinical narrative: Coughing; blood when she spits; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing) and HAEMOPTYSIS (blood when she spits) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced COUGH (Coughing) and HAEMOPTYSIS (blood when she spits). At the time of the report, COUGH (Coughing) and HAEMOPTYSIS (blood when she spits) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.   This case was linked to MOD-2021-089292 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Her arm was now swollen; Bright red; Warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Her arm was now swollen), VACCINATION SITE ERYTHEMA (Bright red) and VACCINATION SITE WARMTH (Warm to touch) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, FLUOXETINE HYDROCHLORIDE (PROZAC), ALPRAZOLAM (XANAX), OMEPRAZOLE, PHENYLAMINE, TRAZODONE and CETIRIZINE HYDROCHLORIDE (ZYRTEK) for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Her arm was now swollen), VACCINATION SITE ERYTHEMA (Bright red) and VACCINATION SITE WARMTH (Warm to touch). At the time of the report, VACCINATION SITE SWELLING (Her arm was now swollen), VACCINATION SITE ERYTHEMA (Bright red) and VACCINATION SITE WARMTH (Warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She wanted to know what she should do?
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Vaccination site pain, Vaccination site warmth
Clinical narrative: Stung really bad; It was on fire; Burned really bad as she was getting it; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE WARMTH (It was on fire), BURNING SENSATION (Burned really bad as she was getting it) and VACCINATION SITE PAIN (Stung really bad) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE WARMTH (It was on fire) and BURNING SENSATION (Burned really bad as she was getting it). On an unknown date, the patient experienced VACCINATION SITE PAIN (Stung really bad). At the time of the report, VACCINATION SITE WARMTH (It was on fire), BURNING SENSATION (Burned really bad as she was getting it) and VACCINATION SITE PAIN (Stung really bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 007B21A) for COVID-19 vaccination.     Medical history was not provided.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) had resolved. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable. Treatment medication information was not provided. Concomitant medication information was not provided.   This case was linked to MOD-2021-089388.   Reporter did not allow further contact
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Left arm is swollen; Left arm is hard; Left arm is red; Left arm is hot to the touch and warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Left arm is swollen), VACCINATION SITE INDURATION (Left arm is hard), VACCINATION SITE ERYTHEMA (Left arm is red) and VACCINATION SITE WARMTH (Left arm is hot to the touch and warm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Blood pressure medicine, Waterpill, Diabetic medication, Cholesterol pill and Bunch of vitamins for an unknown indication.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Left arm is swollen), VACCINATION SITE INDURATION (Left arm is hard), VACCINATION SITE ERYTHEMA (Left arm is red) and VACCINATION SITE WARMTH (Left arm is hot to the touch and warm). At the time of the report, VACCINATION SITE SWELLING (Left arm is swollen), VACCINATION SITE INDURATION (Left arm is hard), VACCINATION SITE ERYTHEMA (Left arm is red) and VACCINATION SITE WARMTH (Left arm is hot to the touch and warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   She used Benadryl and Pain medicine for her symptoms
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Circumoral swelling, Eye swelling, Hypersensitivity, Oral mucosal erythema, Swollen tear duct
Clinical narrative: may be having delayed hypersensitivity reaction to filler; swelling where tear duct is, under the left eye was all swollen; eye on the right side is also swollen; all lumpy and red around mouth; all lumpy and red around mouth; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (may be having delayed hypersensitivity reaction to filler), SWOLLEN TEAR DUCT (swelling where tear duct is, under the left eye was all swollen), EYE SWELLING (eye on the right side is also swollen), ORAL MUCOSAL ERYTHEMA (all lumpy and red around mouth) and CIRCUMORAL SWELLING (all lumpy and red around mouth) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 010A21A) for COVID-19 vaccination.     The patient's past medical history included Dermal filler injection (The patient had injection fillers on her face along tear duct under the eye where there was dark circles and lines around mouth.) in December 2019 and Orthopedic procedure (Wrist) on 22-Apr-2021.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced HYPERSENSITIVITY (may be having delayed hypersensitivity reaction to filler), SWOLLEN TEAR DUCT (swelling where tear duct is, under the left eye was all swollen), EYE SWELLING (eye on the right side is also swollen), ORAL MUCOSAL ERYTHEMA (all lumpy and red around mouth) and CIRCUMORAL SWELLING (all lumpy and red around mouth). The patient was treated with IBUPROFEN at an unspecified dose and frequency and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (may be having delayed hypersensitivity reaction to filler), SWOLLEN TEAR DUCT (swelling where tear duct is, under the left eye was all swollen), EYE SWELLING (eye on the right side is also swollen), ORAL MUCOSAL ERYTHEMA (all lumpy and red around mouth) and CIRCUMORAL SWELLING (all lumpy and red around mouth) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information for the events included were ibuprofen, heat and diphenhydramine. On 22 Apr 2021, the patient was give general anesthesia she was given steroids for orthopedic surgery to her wrist and now symptoms got better. Action taken with v was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site rash
Clinical narrative: arm soreness; reddish rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) and VACCINATION SITE RASH (reddish rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and VACCINATION SITE RASH (reddish rash). On 01-Apr-2021, VACCINATION SITE RASH (reddish rash) had resolved. On 03-Apr-2021, PAIN IN EXTREMITY (arm soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication and treatment information provided.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, General symptom, Headache, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of rhinorrhea (a runny nose), oropharyngeal pain (really bad sore throat), got COVID-19, general symptoms (pretty mild symptoms) and really bad headache in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 02SJ202A) for COVID-19 immunization. No medical history reported. On Jan 28, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 28, 2021, patient experienced rhinorrhea (a runny nose), oropharyngeal pain (really bad sore throat), got COVID-19, general symptom (pretty mild symptoms) and really bad headache. On Feb 4, 2021, rhinorrhea (a runny nose), oropharyngeal pain (really bad sore throat), got COVID-19, general symptoms (pretty mild symptoms) and really bad headache resolved. Diagnostic results: On Jan 28, 2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information reported. This case linked to MOD-2021-089411 (patient link).